Trade Mark Journal No.2026/002 9 January 2026

UK00004313386 19 December 2025 (5)

KYPOWZA

International priority date claimed: 23 June 2025 (United States of America) (99248614)

Class 5: Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; stem cells for medical purposes; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes; radiopharmaceutical preparations for the treatment of cancer and immune system related diseases and disorders.

Juno Therapeutics, Inc.

Representative: Sipara Limited